TAH3311 ODF

· TAHO Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAH3311 ODF, covering 2025-04-11 to 2025-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Pivotal BE Study of TAH3311 ODF vs ELIQUIS® Tablet Under Fasted Condition in Healthy Volunteers [Phase 2]